ConductScience.org, home

Paper35112802

Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.

Huck BC and 19 others. Adv Healthc Mater, 2022. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. Papers, record 35112802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35112802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
PubMed
Journal
Adv Healthc Mater
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2026-09-23
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huck BCBenedikt C
2Thiyagarajan DDurairaj
3Bali AAghiad
4Boese AAnnette
5Besecke KFWKaren F W
6Hozsa CConstantin
7Gieseler RKRobert K
8Furch MMarcus
9Carvalho-Wodarz CCristiane
10Waldow FFranziska
11Schwudke DDominik
12Metelkina OOlga
13Titz AAlexander
14Huwer HHanno
15Schwarzkopf KKonrad
16Hoppstädter JJessica
17Kiemer AKAlexandra K
18Koch MMarcus
19Loretz BBrigittahttps://orcid.org/0000-0003-0057-5181
20Lehr CMClaus-Michaelhttps://orcid.org/0000-0002-5864-8462

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
LiposomesMajor topic
Administration, Inhalation
Aerosols
Dry Powder Inhalers
Fucose
Lung
Macrophages
Particle Size
Powders

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125629008Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan.Front Cell Infect Microbiol2014https://conductscience.org/library/papers/25629008PubMed
27594549Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.J Immunol1995https://conductscience.org/library/papers/7594549PubMed
39609735Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria.Am J Physiol1998https://conductscience.org/library/papers/9609735PubMed
419236209Recent advances in liposomal dry powder formulations: preparation and evaluation.Expert Opin Drug Deliv2009https://conductscience.org/library/papers/19236209PubMed
514568408Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.J Control Release2003https://conductscience.org/library/papers/14568408PubMed
625940082In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.AAPS J2015https://conductscience.org/library/papers/25940082PubMed
721512579Targeted liposomal drug delivery to monocytes and macrophages.J Drug Deliv2011https://conductscience.org/library/papers/21512579PubMed
829626567Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.J Microbiol Methods2018https://conductscience.org/library/papers/29626567PubMed
916382966Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations.Environ Sci Technol2005https://conductscience.org/library/papers/16382966PubMed
1035112802
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
Adv Healthc Mater2022https://conductscience.org/library/papers/35112802PubMed
1133865899Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells.J Control Release2021https://conductscience.org/library/papers/33865899PubMed
1229534242Air-Liquid Interface: Relevant In Vitro Models for Investigating Air Pollutant-Induced Pulmonary Toxicity.Toxicol Sci2018https://conductscience.org/library/papers/29534242PubMed
1323583840Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.Int J Pharm2013https://conductscience.org/library/papers/23583840PubMed
1423262166Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.Eur J Pharm Biopharm2013https://conductscience.org/library/papers/23262166PubMed
1522290346Mycobacterium abscessus: a new antibiotic nightmare.J Antimicrob Chemother2012https://conductscience.org/library/papers/22290346PubMed
1628290290Mucus interactions with liposomes encapsulating bioactives: Interfacial tensiometry and cellular uptake on Caco-2 and cocultures of Caco-2/HT29-MTX.Food Res Int2017https://conductscience.org/library/papers/28290290PubMed
1728373109Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.Eur J Pharm Biopharm2017https://conductscience.org/library/papers/28373109PubMed
1829867826Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.Front Microbiol2018https://conductscience.org/library/papers/29867826PubMed
1934101127Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals.Drug Deliv Transl Res2021https://conductscience.org/library/papers/34101127PubMed
2032781595General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus.J Clin Med2020https://conductscience.org/library/papers/32781595PubMed

See all 71 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42130023One-Step Microfluidic Manufactured Fucose-Decorated Sweetosomes Choose the Time and the Road for Their Intracellular Journey to Cancer Treatment.Adv Healthc Mater2026https://conductscience.org/library/papers/42130023PubMed
42032391Bioactive co-assembly of PSA/diT-VES nanomicelles orchestrates macrophage reprogramming for acute lung injury therapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42032391PubMed
41969646Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery.Bioact Mater2026https://conductscience.org/library/papers/41969646PubMed
40724029Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.Antibiotics (Basel)2025https://conductscience.org/library/papers/40724029PubMed
40478382Bisphosphonates loaded nanoparticles in microparticles: a potential macrophage targeting and repolarizing drug delivery system.Drug Deliv Transl Res2026https://conductscience.org/library/papers/40478382PubMed
40124344Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?Mater Today Bio2025https://conductscience.org/library/papers/40124344PubMed
39141300Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery.Methods Mol Biol2024https://conductscience.org/library/papers/39141300PubMed
39136125Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects.ACS Infect Dis2024https://conductscience.org/library/papers/39136125PubMed
38577780Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.ACS Infect Dis2024https://conductscience.org/library/papers/38577780PubMed
38543241State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives.Pharmaceutics2024https://conductscience.org/library/papers/38543241PubMed
38384321Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review.Int J Nanomedicine2024https://conductscience.org/library/papers/38384321PubMed
38341386Antibiotic resistance and tolerance: What can drug delivery do against this global threat?Drug Deliv Transl Res2024https://conductscience.org/library/papers/38341386PubMed
36839715Nanosized Drug Delivery Systems to Fight Tuberculosis.Pharmaceutics2023https://conductscience.org/library/papers/36839715PubMed
35112802
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
Adv Healthc Mater2022https://conductscience.org/library/papers/35112802PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35112802

GET https://conductscience.org/api/papers/v1/35112802/references?page=2